LIPOPROTEIN(A)
Clinical trials for LIPOPROTEIN(A) explained in plain language.
Never miss a new study
Get alerted when new LIPOPROTEIN(A) trials appear
Sign up with your email to follow new studies for LIPOPROTEIN(A), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets hidden heart risk in people with high lp(a)
Disease control Recruiting nowThis study tests a drug called lepodisiran in 252 adults with high levels of Lp(a), a protein linked to heart disease. Participants must have heart disease or be at risk for a first heart event. The drug is given as an injection and compared to a placebo to see if it reduces plaq…
Matched conditions: LIPOPROTEIN(A)
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New study checks for little-known cholesterol risk in primary care
Knowledge-focused Recruiting nowThis study screens 30 adults at a primary care clinic to find out how many have high levels of lipoprotein(a), a genetic risk factor for heart disease. Participants give a blood sample and researchers measure their cholesterol markers. The goal is to gather data for better heart …
Matched conditions: LIPOPROTEIN(A)
Sponsor: University of Central Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
AI-Powered heart scans could predict heart attacks before they strike
Knowledge-focused Recruiting nowThis observational study will enroll 10,000 adults who are already scheduled for a cardiac CT scan. Researchers will use artificial intelligence to analyze the scans, looking for subtle signs of dangerous plaque that might predict future heart attacks. Participants will also give…
Matched conditions: LIPOPROTEIN(A)
Sponsor: University of Galway • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC